Sanofi Aventis

Welcome to the 'Sanofi Aventis' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Sanofi Aventis'.

Latest blogosphere posts tagged “Sanofi Aventis”

• Sanofi Sales Rep Sues For Overtime Pay

  
  Pharmalot — Authority: 528
  Yet another sales rep has joined the battle about overtime pay. The latest involves a Sanofi-Aventis rep in Minnesota, Dede Evavold, who alleges in a putative class action lawsuit ( see here ) that she and others were denied overtime pay in violation of federal law. Typically, sales reps argue they are not exempt from ...
  1 day ago

• (AMLN) Amylin Pharmaceuticals Impresses in Head-to-Head

  
  Stock Blog Hub — Authority: 459
  Amylin Pharmaceuticals, Inc. ( AMLN ) recently announced positive results on its once weekly formulation of Byetta (referred to as exenatide once weekly), which is being developed in collaboration with Eli Lilly and Company ( LLY ) and Alkermes, Inc. ( ALKS ). Amylin presented results from a head-to-head study ...
  1 day ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 528
  Rise and shine, everyone, another day has begun. And as the Morning Mayor used to say, every brand new day should be unwrapped like a precious gift. As you can tell, we like comforting thoughts. So as you unwrap your proverbial ribbon, we have assembled a few items to help you along. Whatever you do today, we hope you ...
  2 days ago

• Recall: 800,000 Doses of Swine flu Vaccine

  
  Kreuzer's Korner — Authority: 140
  Sanofi-Aventis is recalling 800,000 doses of H1N1 vaccine meant for children younger than 3 because the vaccine has lost potency. Hmmm… From CNN : The French manufacturer Sanofi Pasteur is voluntarily recalling about 800,000 doses of vaccine meant for children between the ages of 6 months and 35 months. ...
  2 days ago

• State received recalled H1N1 vaccine

  
  Michigan Messenger — Authority: 591
  The Michigan Department of Community Health announced Tuesday some state children may have been vaccinated against influenza A (H1N1) with vaccine from a recalled lot. Sanofi-Aventis SA, maker of the vaccine, recalled 800,000 pediatric doses, a press release from MDCH notes, because “tests found the potency was ...
  2 days ago

• 800,000 Swine Flu Vaccines Recalled Due to Fading Potency

  
  Wall Street Pit — Authority: 655
  Health officials have recalled 800,000 doses of swine flu vaccine for children because tests indicate the vaccine doses lost some strength and may not be potent enough to protect against the virus, federal officials said today.The Centers for Disease Control and Prevention issued an alert about...
  2 days ago

• Bristol-Myers Squibb, Sanofi-Aventis Tops Pharmaceutical Sustainability Report

  
  Environmental Leader — Authority: 623
  Bristol-Myers Squibb and Sanofi-Aventis earned the two highest scores in the pharmaceutical sector for sustainability reporting, according to a report from the Roberts Environmental Center (REC) at Claremont McKenna College.The report, “Sustainability Reporting of the World’s Largest Pharmaceutical Companies,” ...
  3 days ago

• Country’s first Oral vaccine against cholera launched on Monday

  
  UwidoNews - Submitted news — Authority: 172
  Shantha, which was recently acquired by Sanofi Pasteur the vaccines division of the Sanofi-Aventis Group -- on Monday, launched Shanchol, the country’s first oral vaccine to protect individuals older than two years against cholera.
  3 days ago

• Impactiviti Daily 121409

  
  Impactiviti blog — Authority: 120
  TODAY’S NEWS Sanofi - now laying off contract sales reps and some others. Pfizer and compliance . That’s a lot of corporate integrity agreements (from PharmaGossip blog) From the NYTimes: Menopause, as brought to you by Big Pharma – MILLIONS of American women in the 1990s were told they could ...
  4 days ago

• You can profit from James Altuchers insanity

  
  BloggingStocks — Authority: 676
  Filed under: Newspapers , Interviews , Columns , Books , Entrepreneurs James Altucher is a financial journalist for The Wall Street Journal and founder of Stockpickr.com. His articles cover every angle of the market; he also stars in feature videos with other financial luminaries. He is the author of Trade ...
  5 days ago

• Ready to rumble: Pfizers generic biotech drug push could pit it against Amgen

  
  DailyFinance — Authority: 773
  Filed under: Company News , Healthcare For years, Pfizer ( PFE ) has been trying to prepare for the "patent cliff" its heading for in 2011. Thats when its cholesterol drug Lipitor -- the biggest-selling drug ever with $12 billion in annual sales -- will fall off the rolls of protected drugs. Mindful of that date, ...
  1 week ago

• (REGN) Regeneron Pharmaceuticals to Expand Research Positions

  
  Stock Blog Hub — Authority: 459
  Regeneron Pharmaceuticals Inc. ( REGN ) announced recently that is investing $40 million, which will result in the creation of up to 100 jobs in East Greenbush facility in Rensselaer County, coupled with another 300 jobs at its Westchester County facility, both in New York. The new positions will be created primarily ...
  1 week ago

• Impactiviti Daily 121009

  
  Impactiviti blog — Authority: 120
  TODAY’S NEWS So…is Roche ’s Tamiflu really that effective? – The effectiveness of Roche Holding AG’s Tamiflu in treating flu complications in healthy adults can’t be determined because the Swiss drugmaker wouldn’t supply data from eight studies, an independent research group said … more The ...
  1 week ago

• Ten stocks for 2010

  
  DailyFinance — Authority: 773
  Filed under: Investing , GlaxoSmithKline By many measures, this past decade was a downer. We experienced the dot-com bust, terrorism attacks, the Enron scandal, Bernie Madoffs Ponzi scheme, at least two wars and the Jonas Brothers. Oh, and lest I forget, one of worst financial crises in history. For anyone ...
  1 week ago

• Impactiviti Daily 120909

  
  Impactiviti blog — Authority: 120
  TODAY’S NEWS Novartis’ “son of Glivec” (Tasigna) carrying on the family tradition – Novartis has reported result of Tasigna Phase III clinical trial. In the study, Tasigna (nilotinib) demonstrated greater efficacy over Glivec (imatinib) in the treatment of adult patients with newly diagnosed ...
  1 week ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 528
  Hello, everyone. There is a great deal of rain falling on the Pharmalot corporate campus this morning, but the pitter patter does not deter us. After all, there is much to do - the usual pile of deadlines and projects awaits. So as we reach for the traditional cup of stimulation, please join us in meeting another day. ...
  1 week ago

• FIBRILLAZIONE ATRIALE: APPROVATO IL DRONEDARONE

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 150
  Sanofi-aventis ha annunciato che la Commissione Europea ha accordato lautorizzazione per la commercializzazione di dronedarone (compresse da 400 mg) in tutti i 27 Stati Membri dell’Unione Europea. Tale approvazione fa seguito allopinione positiva espressa lo scorso 25 Settembre dal Comitato per i Prodotti ...
  1 week ago

• Pharma Unplugged #2 Layoffs & Bonuses

  
  PharmExec Blog — Authority: 115
  Pharma Unplugged #2— Layoffs & Bonuses Recorded: 12/3/2009 Air Date: 12/7/2009 Host: George Koroneos, Pharm Exec Cohost: Reid Paul, Pharm Rep Magazine Show Notes: This week we discuss: Pfizer’s medical education relationship with the Canadian Medical Association Journalists take FDA to task for ...
  1 week ago

• (CYTR) Good News for CytRx Corporation

  
  Stock Blog Hub — Authority: 459
  CytRx Corp. ( CYTR ) announced that the U.S. Food and Drug Administration (FDA) lifted a clinical hold on its molecular chaperone candidate arimoclomol for treating patients suffering from amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease). The agency accepted a revised trial protocol while removing the ...
  1 week ago

• (LLY) Eli Lilly & Company’s Effient Proves Its Worth

  
  Stock Blog Hub — Authority: 459
  Recently, Eli Lilly & Co.’s ( LLY ) Effient (prasugrel) received a major boost when it was added as a treatment option in two clinical guideline updates. These were for patients receiving percutaneous coronary intervention (PCI) and for patients with ST elevation myocardial infarction (STEMI), or severe heart ...
  1 week ago

Comments about Sanofi Aventis